Jay Giri, MD, MPH
June 17th, 2014
A Meta-Look at Thrombolysis vs. Conventional Anticoagulation for PE
Jay Giri, MD, MPH and Saurav Chatterjee, MD
Jay Giri and Saurav Chatterjee discuss their meta-analysis of trials comparing thrombolytic therapy and conventional anticoagulation in patients at intermediate risk for pulmonary embolism.
January 16th, 2014
Are All Carotid Stenting Systems Equal?
Jay Giri, MD, MPH and Robert W. Yeh, MD MSc MBA
Jay Giri and Robert W. Yeh discuss their research group’s analysis of patient-registry data on embolic protection devices that are commonly used in carotid artery stenting.
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy